KEMRI targets Marigat, Chemolingot hospitals in push to combat Hepatitis B and Kala-Azar
The Kenya Medical Research Institute (KEMRI) is establishing model health facilities in Marigat and Chemolingot to combat Hepatitis B and Kala-azar. These initiatives aim to provide critical care and disease management in regions where these infections are endemic.
Why it matters
Targeted medical infrastructure in underserved regions is essential for controlling the spread of infectious diseases and reducing mortality rates.
KEMRI Chief Executive Officer Prof Elijah Songok said the establishment of the two model health facilities is aimed at eradicating the endemic diseases in the region.
The article provides a straightforward report on public health initiatives without political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in